Skip to main content

Volume 4 Supplement 1

Second Annual International African-Caribbean Cancer Consortium Conference

Proceedings

Edited by Camille Ragin and Emanuela Taioli

Publication supported in part by the University Of Pittsburgh Graduate School Of Public Health, the University of Pittsburgh Cancer Institute, and by the National Institute of Health, grant number R13CA130596A.

Second Annual International African-Caribbean Cancer Consortium Conference. Go to conference site.

Miami, FL, USA12-13 May 2008

  2. African American men have the highest prostate cancer morbidity and mortality rates than any other racial or ethnic group in the US. Although the overall incidence of and mortality from prostate cancer has bee...

    Authors: Folakemi T Odedina, Titilola O Akinremi, Frank Chinegwundoh, Robin Roberts, Daohai Yu, R Renee Reams, Matthew L Freedman, Brian Rivers, B Lee Green and Nagi Kumar
    Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S2
    Content type: Proceedings Published on:

  3. African American Men are 65% more likely to develop prostate cancer and are twice as likely to die of prostate cancer, than are Caucasian American Males. The explanation for this glaring health disparity is st...

    Authors: R Renee Reams, Deepak Agrawal, Melissa B Davis, Sean Yoder, Folakemi T Odedina, Nagi Kumar, Joseph M Higginbotham, Titilola Akinremi, Sandra Suther and Karam FA Soliman
    Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S3
    Content type: Proceedings Published on:

  5. Morbidity and mortality data highlight prostate cancer as the most commonly diagnosed neoplasm in Jamaican males. This report examines the association between dietary patterns and risk of prostate cancer in Ja...

    Authors: Maria Jackson, Susan Walker, Candace Simpson, Norma McFarlane-Anderson and Franklyn Bennett
    Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S5
    Content type: Proceedings Published on:

  7. The Cancer Registry of Guyana, a population-based registry was established in 2000. Over the past eight years, data has been collected from the national referral hospital and other public and private instituti...

    Authors: Wallis S Best Plummer, Premini Persaud and Penelope J Layne
    Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S7
    Content type: Proceedings Published on:

  8. The human papillomavirus (HPV) is the major etiologic agent in the development of cervical cancer and its natural history of infection is altered in persons infected with the human immunodeficiency virus (HIV)...

    Authors: Dionne N Dames, Camille Ragin, Andrea Griffith-Bowe, Perry Gomez and Raleigh Butler
    Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S8
    Content type: Proceedings Published on:

  9. Disparities in cervical cancer incidence and mortality rates exist among women of African ancestry (African-American, African-Caribbean and African). Persistent cervical infection with Human papillomavirus (HP...

    Authors: Camille C Ragin, Angela Watt, Nina Markovic, Clareann H Bunker, Robert P Edwards, Stacy Eckstein, Horace Fletcher, David Garwood, Susanne M Gollin, Maria Jackson, Alan L Patrick, M Smikle, Emanuela Taioli, Victor W Wheeler, Jacque B Wilson, N Younger…
    Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S9
    Content type: Proceedings Published on:

  10. The United States (US) Food & Drug Administration (FDA) recently approved a human papillomavirus (HPV) vaccine with the purpose of reducing the risk of cervical cancers caused by HPV 16 and HPV 18. It is impor...

    Authors: Camille C Ragin, Robert P Edwards, Jade Jones, Natalie E Thurman, Kourtney L Hagan, Erin A Jones, Cierra M Moss, Ar'Lena C Smith, Aletha Akers, Susanne M Gollin, Dwight E Heron, Cecile Andraos-Selim, Cornelius Bondzi, Linda Robertson and Emanuela Taioli
    Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S10
    Content type: Proceedings Published on:

  11. Vaccines, that target human papillomavirus (HPV) high risk genotypes 16 and 18, have recently been developed. This study was aimed at determining genotypes commonly found in high-risk and multiple-HPV infectio...

    Authors: Angela Watt, David Garwood, Maria Jackson, Novie Younger, Camille Ragin, Monica Smikle, Horace Fletcher and Norma McFarlane-Anderson
    Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S11
    Content type: Proceedings Published on:

  12. Cytochrome P450 1B1 (CYP1B1) is active in the metabolism of estrogens to reactive catechols and of different procarcinogens. Several studies have investigated the relationship between genetic polymorphisms of CYP...

    Authors: Michael N Okobia, Clareann H Bunker, Seymour J Garte, Joseph M Zmuda, Emmanuel R Ezeome, Stanley NC Anyanwu, Emmanuel EO Uche, Usifo Osime, Joseph Ojukwu, Lewis H Kuller, Robert E Ferrell and Emanuela Taioli
    Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S12
    Content type: Proceedings Published on:

  13. The leptin receptor gene (LEPR) polymorphism Q223R is one of the most common in the general population, and is thought to be associated with an impaired signaling capacity of the leptin receptor and with higher m...

    Authors: Camille C Ragin, Cher Dallal, Michael Okobia, Francesmary Modugno, Jiangying Chen, Seymour Garte and Emanuela Taioli
    Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S13
    Content type: Proceedings Published on:

  15. It has been noted that the African American population in the U.S. bears disproportionately higher cancer morbidity and mortality rates than any racial and ethnic group for most major cancers. Many studies als...

    Authors: Natalie Thurman, Camille Ragin, Dwight E Heron, Renae J Alford, Cecile Andraos-Selim, Cornelius Bondzi, Jamila A Butcher, Jamison C Coleman, Charity Glass, Barbara Klewien, Aerie T Minor, Diana J Williams and Emanuela Taioli
    Citation: Infectious Agents and Cancer 2009 4(Suppl 1):S15
    Content type: Proceedings Published on:

Follow

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.1
    5-year Journal Impact Factor: 3.3
    Source Normalized Impact per Paper (SNIP): 0.810
    SCImago Journal Rank (SJR): 0.424

    Speed 2023
    Submission to first editorial decision (median days): 12
    Submission to acceptance (median days): 112

    Usage 2023
    Downloads: 687,750
    Altmetric mentions: 813

What is trending?

Altmetric




               Click here to see which articles published in Infectious Agents and Cancer have been shared the most in the past three months.

Infectious Agents and Cancer

ISSN: 1750-9378

Contact us